Page History
Anchor | ||||
---|---|---|---|---|
|
...
...
The system will not display this section if you indicated that you do not require an XML document for ClinicalTrials.gov.
HTML Comment | ||
---|---|---|
| ||
Screenshot TBD. |
How to Complete the Regulatory Information Section
Select or enter the appropriate information in the text fields and drop-down lists. The following table describes the fields. An asterisk (*) indicates a required field. See the ClinicalTrials.gov Protocol Data Element Definitions for definitions for these fieldsFor a definition of each field, refer to http://prsinfo.clinicaltrials.gov/definitions.html.
Instructions for recording regulatory information
Field Label | Description/Instructions | ||||||||
---|---|---|---|---|---|---|---|---|---|
Studies a U.S. FDA-regulated Drug Product* |
| ||||||||
Studies a U.S. FDA-regulated Device Product* |
| ||||||||
Unapproved/Uncleared Device* |
| ||||||||
Pediatric Post-market Surveillance |
| ||||||||
Product Exported from the U.S. |
| ||||||||
FDA Regulated Intervention Indicator* |
| ||||||||
Section 801 Indicator* |
| ||||||||
Data Monitoring Committee Appointed Indicator Optionally, indicate whether a data monitoring committee has been appointed for this trial by selecting Yes or No. Info | |
|